Excelimmune Secures $5,000,000 Series B Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    12-B Cabot Road Woburn, MA 01801
  • Company Description
    Excelimmune Inc., based in Cambridge, is a biotechnology company developing therapuetic applications of human recombinant polyclonal antibodies.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    In addition to doubling Excelimmune’s size over the past year, this funding provides us with the capital required to enter the next stage of our product and technology development.
  • M&A Terms
  • Venture Investor

Trending on Xconomy